Contract award · 22 Apr 2026

Provision of Assay Kits for SCID Evaluation: EONIS-Q

NHS England awarded “Provision of Assay Kits for SCID Evaluation: EONIS-Q” to Revvity (UK) Limited for £950k on 22 Apr 2026.

Health & social careYorkshire and the Humber

BuyerNHS England
Value £950k

Competition with a shortlist

Competitive procedure with a selection stage: suppliers were shortlisted before being invited to bid.

Key facts

Buyer
NHS England · Body governed by public law
Value
£949,936.80
Procedure
Call-off from a framework agreement
Sector
Health & social care · Health services (CPV 85100000)
Timeline
  1. Contract date22 Apr 2026
  2. Published22 Apr 2026Published the same day

Description

his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combined Immuno-Deficiency (SCID) in-service evaluation (ISE) in 4 Screening laboratories.

About the supplier

More from NHS England

All contracts

More won by Revvity (UK) Limited

All contracts

Recent health & social care contracts

Sector overview